Blog
Omics-Based Clinical Trials Market to reach $61.98 Bn by 2032 growing at a CAGR of 8.36%
The omics-based clinical trials market continues to demonstrate strong global momentum as pharmaceutical and biotechnology companies increasingly integrate genomics, proteomics, metabolomics, and transcriptomics into their
SNS Insider
November 19, 2025